iBio, Inc. Annual Deferred Federal Income Tax Expense (Benefit) in USD from 2011 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2011 to 2024.
- iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2024 was -$5.19M, a 57.3% increase from 2023.
- iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$12.2M, a 34.3% decline from 2022.
- iBio, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$9.05M, a 16356% decline from 2021.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)